John R. Bringas

3.6k total citations
54 papers, 2.8k citations indexed

About

John R. Bringas is a scholar working on Genetics, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, John R. Bringas has authored 54 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 23 papers in Cellular and Molecular Neuroscience and 17 papers in Molecular Biology. Recurrent topics in John R. Bringas's work include Virus-based gene therapy research (26 papers), Neurological disorders and treatments (14 papers) and Nerve injury and regeneration (13 papers). John R. Bringas is often cited by papers focused on Virus-based gene therapy research (26 papers), Neurological disorders and treatments (14 papers) and Nerve injury and regeneration (13 papers). John R. Bringas collaborates with scholars based in United States, Italy and United Kingdom. John R. Bringas's co-authors include Krystof S. Bankiewicz, John Forsayeth, Jamie L. Eberling, Piotr Hadaczek, Janet Cunningham, Philip Pivirotto, Phillip Pivirotto, Adrian P. Kells, Krys S. Bankiewicz and Mitchel S. Berger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Neuroscience.

In The Last Decade

John R. Bringas

54 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John R. Bringas United States 31 1.3k 1.2k 1.0k 788 311 54 2.8k
Piotr Hadaczek United States 34 974 0.7× 1.5k 1.3× 1.1k 1.0× 536 0.7× 202 0.6× 64 3.0k
Adrian P. Kells United States 28 1.2k 0.9× 1.2k 1.0× 937 0.9× 555 0.7× 265 0.9× 50 2.5k
Andrew Freese United States 31 729 0.5× 1.4k 1.2× 951 0.9× 237 0.3× 287 0.9× 54 3.2k
Stuart Walbridge United States 38 583 0.4× 1.4k 1.1× 808 0.8× 554 0.7× 831 2.7× 69 3.6k
Mimoun Azzouz United Kingdom 31 956 0.7× 2.2k 1.8× 827 0.8× 1.3k 1.6× 1.3k 4.3× 77 3.8k
Mehdi Gasmi United States 26 826 0.6× 1.0k 0.9× 662 0.6× 480 0.6× 149 0.5× 46 2.2k
X. O. Breakefield United States 29 950 0.7× 1.4k 1.1× 1.2k 1.2× 687 0.9× 139 0.4× 54 2.9k
John R. Bringas United States 22 446 0.3× 719 0.6× 499 0.5× 428 0.5× 440 1.4× 29 1.9k
Philip H. Schwartz United States 29 723 0.5× 2.1k 1.7× 699 0.7× 125 0.2× 480 1.5× 78 3.7k
Marta Nieto Spain 29 1.1k 0.9× 2.2k 1.9× 480 0.5× 169 0.2× 456 1.5× 54 4.9k

Countries citing papers authored by John R. Bringas

Since Specialization
Citations

This map shows the geographic impact of John R. Bringas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Bringas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Bringas more than expected).

Fields of papers citing papers by John R. Bringas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Bringas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Bringas. The network helps show where John R. Bringas may publish in the future.

Co-authorship network of co-authors of John R. Bringas

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Bringas. A scholar is included among the top collaborators of John R. Bringas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Bringas. John R. Bringas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ford, Matthew M., Victor S. Van Laar, Katherine M. Holleran, et al.. (2023). GDNF gene therapy for alcohol use disorder in male non-human primates. Nature Medicine. 29(8). 2030–2040. 12 indexed citations
2.
Samaranch, Lluı́s, Bas Blits, Waldy San Sebastián, et al.. (2017). MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain. Gene Therapy. 24(4). 253–261. 61 indexed citations
3.
Hadaczek, Piotr, Lisa M. Stanek, Agnieszka Ciesielska, et al.. (2016). Widespread AAV1- and AAV2-mediated transgene expression in the nonhuman primate brain: implications for Huntington's disease. Molecular Therapy — Methods & Clinical Development. 3. 16037–16037. 33 indexed citations
4.
Salegio, Ernesto A., John R. Bringas, & Krystof S. Bankiewicz. (2015). MRI-Guided Delivery of Viral Vectors. Methods in molecular biology. 1382. 217–230. 12 indexed citations
5.
Sebastián, Waldy San, Adrian P. Kells, John R. Bringas, et al.. (2014). Safety and tolerability of MRI-guided infusion of AAV2-hAADC into the mid-brain of nonhuman primate. Molecular Therapy — Methods & Clinical Development. 1. 14049–14049. 27 indexed citations
6.
Sebastián, Waldy San, Lluı́s Samaranch, Gregory Heller, et al.. (2013). Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain. Gene Therapy. 20(12). 1178–1183. 45 indexed citations
7.
Salegio, Ernesto A., Lluı́s Samaranch, Russell W. Jenkins, et al.. (2012). Safety Study of Adeno-Associated Virus Serotype 2-Mediated Human Acid Sphingomyelinase Expression in the Nonhuman Primate Brain. Human Gene Therapy. 23(8). 891–902. 19 indexed citations
8.
Rosenbluth, Kathryn H., Alastair J. Martin, John R. Bringas, & Krystof S. Bankiewicz. (2012). Evaluation of pressure‐driven brain infusions in nonhuman primates by intra‐operative 7 tesla MRI. Journal of Magnetic Resonance Imaging. 36(6). 1339–1346. 11 indexed citations
9.
Ziegler, Robin J., Ernesto A. Salegio, James C. Dodge, et al.. (2011). Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion. Experimental Neurology. 231(2). 261–271. 23 indexed citations
10.
Rosenbluth, Kathryn H., Matthias Luz, Erich Mohr, et al.. (2010). Design of an in-dwelling cannula for convection-enhanced delivery. Journal of Neuroscience Methods. 196(1). 118–123. 21 indexed citations
11.
Hadaczek, Piotr, Jamie L. Eberling, Philip Pivirotto, et al.. (2010). Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC. Molecular Therapy. 18(8). 1458–1461. 121 indexed citations
12.
Eberling, Jamie L., Adrian P. Kells, Philip Pivirotto, et al.. (2009). Functional Effects of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Parkinsonian Rhesus Monkeys. Human Gene Therapy. 20(5). 511–518. 80 indexed citations
13.
Yin, Dali, Francisco Valles, Massimo S. Fiandaca, et al.. (2009). Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates. NeuroImage. 54. S196–S203. 50 indexed citations
14.
Cunningham, Janet, Philip Pivirotto, John R. Bringas, et al.. (2008). Biodistribution of Adeno-associated Virus Type-2 in Nonhuman Primates after Convection-enhanced Delivery to Brain. Molecular Therapy. 16(7). 1267–1275. 54 indexed citations
15.
Fiandaca, Massimo S., Vanja Varenika, Jamie L. Eberling, et al.. (2008). Real-time MR imaging of adeno-associated viral vector delivery to the primate brain. NeuroImage. 47. T27–T35. 96 indexed citations
16.
Forsayeth, John, Jamie L. Eberling, Laura Sanftner, et al.. (2006). A Dose-Ranging Study of AAV-hAADC Therapy in Parkinsonian Monkeys. Molecular Therapy. 14(4). 571–577. 80 indexed citations
17.
Krauze, Michal T., Tracy R. McKnight, Yoji Yamashita, et al.. (2005). Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. Brain Research Protocols. 16(1-3). 20–26. 77 indexed citations
18.
19.
Eberling, Jamie L., Krzysztof S. Bankiewicz, Phillip Pivirotto, et al.. (1999). Dopamine transporter loss and clinical changes in MPTP-lesioned primates. Brain Research. 832(1-2). 184–187. 19 indexed citations
20.
Eberling, Jamie L., William J. Jagust, Scott Taylor, et al.. (1998). A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes. Brain Research. 805(1-2). 259–262. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Piotr Hadaczek Breakdown of academic impact, for papers by Adrian P. Kells Breakdown of academic impact, for papers by Andrew Freese Breakdown of academic impact, for papers by Stuart Walbridge Breakdown of academic impact, for papers by Mimoun Azzouz Breakdown of academic impact, for papers by Mehdi Gasmi Breakdown of academic impact, for papers by X. O. Breakefield Breakdown of academic impact, for papers by John R. Bringas Breakdown of academic impact, for papers by Philip H. Schwartz Breakdown of academic impact, for papers by Marta Nieto
Rankless by CCL
2026